Trial
Neurology

Roche: A Phase IIB, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of intravenous prasinezumab in participants with early Parkinson's disease

Active not recruiting

This study will evaluate the efficacy, safety, and pharmacokinetics of prasinezumab compared with placebo in patients with early Parkinson's disease (PD).

Trial
Psychiatry

RECOVER: A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No-Stimulation Control in Subjects with Treatment-Resistant Depression

Active recruiting

The RECOVER study is a nationwide clinical trial that has been approved by Medicare to provide additional evidence for the benefits of Vagus Nerve Stimulation (VNS) Therapy.  Vagus Nerve Stimulation Therapy is an FDA-approved device for treating patients with TRD (Treatment Resistant Depression). It is implanted in the left chest area during a short outpatient procedure. The device delivers mild, intermittently pulsed signals to the vagus nerve in the neck that activate various parts of the brain.

News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
Trial
Neurology

Athira: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study to Evaluate Safety and Efficacy of ATH-1017 Treatment in Alzheimer’s Dementia Patients

Active recruiting

ATH-1017-AD-201: The purpose of this study is to compare the effects, good or bad, of ATH-1017 on patients with mild to moderate Alzheimer's Disease.

Events

Agriculture and Mental Health: Helping In Times of Distress

An Introduction to Helping Skills In this first session, participants will explore elements of a helping/ therapeutic conversation in a 40-minute interactive webinar. Practical application specific to producers and their families will behighlighted, and the webinar will conclude with discussion, questions, and answers. Recognizing Signs of Psychological Distress In the second session, participants will learn to identify typical presentations of depression, anxiety, and suicidality, along with learning triage for suicidal ideation in this 40-minute interactive webinar. Practical application
Events

Agriculture and Mental Health: Helping In Times of Distress

An Introduction to Helping Skills In this first session, participants will explore elements of a helping/ therapeutic conversation in a 40-minute interactive webinar. Practical application specific to producers and their families will behighlighted, and the webinar will conclude with discussion, questions, and answers. Recognizing Signs of Psychological Distress In the second session, participants will learn to identify typical presentations of depression, anxiety, and suicidality, along with learning triage for suicidal ideation in this 40-minute interactive webinar. Practical application
Events

Agriculture and Mental Health: Helping In Times of Distress

An Introduction to Helping Skills In this first session, participants will explore elements of a helping/ therapeutic conversation in a 40-minute interactive webinar. Practical application specific to producers and their families will behighlighted, and the webinar will conclude with discussion, questions, and answers. Recognizing Signs of Psychological Distress In the second session, participants will learn to identify typical presentations of depression, anxiety, and suicidality, along with learning triage for suicidal ideation in this 40-minute interactive webinar. Practical application
General Results

Minds in Motion

Exercise, create, and explore using all five senses. Minds in Motion is an evidence-based program, designed for persons experiencing memory loss or dementia. The goal is to improve or maintain mental, physical and emotional well-being, using all five senses in a variety of activities. Sessions are held twice a month and each session has a different theme to help keep the program fresh. Activities include: Brain games Creative activities Art Music Socialization Chair yoga The Minds in Motion programs are between three and four hours, and allow respite for caregivers if they choose. Caregivers
Subscribe to Patient